Cargando…

Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)

BACKGROUND AND AIMS: To assess experts’ preference for sarcopenia outcomes. METHODS: A discrete-choice experiment was conducted among 37 experts (medical doctors and researchers) from different countries around the world. In the survey, they were repetitively asked to choose which one of two hypothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaudart, Charlotte, Bauer, Jürgen M., Landi, Francesco, Bruyère, Olivier, Reginster, Jean-Yves, Hiligsmann, Mickael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084829/
https://www.ncbi.nlm.nih.gov/pubmed/33666899
http://dx.doi.org/10.1007/s40520-021-01794-2
_version_ 1783686234511507456
author Beaudart, Charlotte
Bauer, Jürgen M.
Landi, Francesco
Bruyère, Olivier
Reginster, Jean-Yves
Hiligsmann, Mickael
author_facet Beaudart, Charlotte
Bauer, Jürgen M.
Landi, Francesco
Bruyère, Olivier
Reginster, Jean-Yves
Hiligsmann, Mickael
author_sort Beaudart, Charlotte
collection PubMed
description BACKGROUND AND AIMS: To assess experts’ preference for sarcopenia outcomes. METHODS: A discrete-choice experiment was conducted among 37 experts (medical doctors and researchers) from different countries around the world. In the survey, they were repetitively asked to choose which one of two hypothetical patients suffering from sarcopenia deserves the most a treatment. The two hypothetical patients differed in five pre-selected sarcopenia outcomes: quality of life, mobility, domestic activities, fatigue and falls. A mixed logit panel model was used to estimate the relative importance of each attribute. RESULTS: All sarcopenia outcomes were shown to be significant, and thus, important for experts. Overall, the most important sarcopenia outcome was falls (27%) followed by domestic activities and mobility (24%), quality of life (15%) and fatigue (10%). DISCUSSION AND CONCLUSION: Compared to patient’s preferences, experts considered falls as a more important outcome of sarcopenia, while the outcomes fatigue and difficulties in domestic activities were considered as less important.
format Online
Article
Text
id pubmed-8084829
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-80848292021-05-05 Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS) Beaudart, Charlotte Bauer, Jürgen M. Landi, Francesco Bruyère, Olivier Reginster, Jean-Yves Hiligsmann, Mickael Aging Clin Exp Res Short Communication BACKGROUND AND AIMS: To assess experts’ preference for sarcopenia outcomes. METHODS: A discrete-choice experiment was conducted among 37 experts (medical doctors and researchers) from different countries around the world. In the survey, they were repetitively asked to choose which one of two hypothetical patients suffering from sarcopenia deserves the most a treatment. The two hypothetical patients differed in five pre-selected sarcopenia outcomes: quality of life, mobility, domestic activities, fatigue and falls. A mixed logit panel model was used to estimate the relative importance of each attribute. RESULTS: All sarcopenia outcomes were shown to be significant, and thus, important for experts. Overall, the most important sarcopenia outcome was falls (27%) followed by domestic activities and mobility (24%), quality of life (15%) and fatigue (10%). DISCUSSION AND CONCLUSION: Compared to patient’s preferences, experts considered falls as a more important outcome of sarcopenia, while the outcomes fatigue and difficulties in domestic activities were considered as less important. Springer International Publishing 2021-03-05 2021 /pmc/articles/PMC8084829/ /pubmed/33666899 http://dx.doi.org/10.1007/s40520-021-01794-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Short Communication
Beaudart, Charlotte
Bauer, Jürgen M.
Landi, Francesco
Bruyère, Olivier
Reginster, Jean-Yves
Hiligsmann, Mickael
Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
title Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
title_full Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
title_fullStr Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
title_full_unstemmed Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
title_short Experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) in collaboration with the European Union of Geriatric Medicine Society (EUGMS)
title_sort experts’ preferences for sarcopenia outcomes: a discrete-choice experiment from a working group of the european society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (esceo) in collaboration with the european union of geriatric medicine society (eugms)
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084829/
https://www.ncbi.nlm.nih.gov/pubmed/33666899
http://dx.doi.org/10.1007/s40520-021-01794-2
work_keys_str_mv AT beaudartcharlotte expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms
AT bauerjurgenm expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms
AT landifrancesco expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms
AT bruyereolivier expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms
AT reginsterjeanyves expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms
AT hiligsmannmickael expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms
AT expertspreferencesforsarcopeniaoutcomesadiscretechoiceexperimentfromaworkinggroupoftheeuropeansocietyforclinicalandeconomicaspectsofosteoporosisosteoarthritisandmusculoskeletaldiseasesesceoincollaborationwiththeeuropeanunionofgeriatricmedicinesocietyeugms